News
Children with SCD who have sleep issues, such as sustained low blood oxygen during sleep, require more healthcare resources, ...
Pociredir 12 mg dose has shown favorable safety and signs of efficacy in a Phase 1b trial of sickle cell disease (SCD).
The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...
Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.
A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...
The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of carbon monoxide.
The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke risk, a study says.
Acute chest syndrome associated with sickle cell is driven by the abnormal activation of the complement cascade, per a study.
The Centers for Medicare & Medicaid Services (CMS) has announced that 33 states, along with the District of Columbia and Puerto Rico, have agreed to participate in the Cell and Gene Therapy (CGT) ...
Children with sickle cell disease can come together for a week of recreation and learning at Camp Hope in North Carolina.
A systematic review found that the quality of life of sickle cell disease patients tends to improve if they receive a stem cell transplant or gene therapy.
Intranasal fentanyl is a feasible, safe, and effective option for managing acute pain episodes in adults with sickle cell disease, a study reports.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results